dr. kalinsky on optical imaging for her2 breast cancer
Published 7 years ago • 196 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
1:10
dr. kalinsky discusses the evolution of her2 breast cancer
-
0:53
dr. kalinsky on cns involvement in her2 breast cancer
-
1:45
dr. kalinsky on neratinib and tucatinib in her2 metastatic breast cancer
-
1:35
dr. kalinsky on ruxolitinib plus trastuzumab in her2-positive breast cancer
-
0:43
dr. kalinsky discusses biosimilars in breast cancer
-
1:20
kevin kalinsky, md, offers considerations when treating patients with hr , her2- breast cancer
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
0:57
dr. marks on the role of tkis in her2-positive breast cancer
-
0:50
dr. white on cns metastases in her2 breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
0:31
get to know her2-positive breast cancer and its targeted treatments
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
1:18
dr. hamilton discusses the katherine trial in her2 breast cancer
-
1:12
dr. pegram on challenges in neoadjuvant treatment for her2-positive breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
0:39
understand the connection between her2 breast cancer & egfr expression #her2positive
-
0:39
science behind nfκb activation in her2 breast cancer & its link with inflammation & cancer #her2